Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,237 public trials 1,175 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NCT07349537

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +30 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

NCT06695845

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +64 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
  • Rocky Mountain Cancer Center Littleton, Colorado, United States
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
View all 28 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

NCT05355701

Conditions
Advanced Colorectal Cancer (Part 1), Bronchial Neoplasms, Carcinoma, Bronchogenic, +28 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Clinical and Translational Research Center (CTRC) Aurora, Colorado, United States
View all 40 locations
View Trial Details
Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

NCT04613596

Conditions
Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Local Institution - 007-556-A Goodyear, Arizona, United States
  • USOR - Arizona Oncology - Prescott Valley Prescott Valley, Arizona, United States
  • Local Institution - 007-568-A Safford, Arizona, United States
  • Local Institution - 007-568-B Safford, Arizona, United States
View all 770 locations
View Trial Details
Recruiting

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

NCT07566052

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Oncura Health d.b.a.Los Angeles Cancer Network Glendale, California, United States
  • Astera Cancer Care Edison, New Jersey, United States
  • Virginia Cancer Specialists Arlington, Virginia, United States
  • Hokkaido University Hospital Sapporo, Hokkaido, Japan
View Trial Details

Related conditions